More people with type 1 diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness

Ozempic & Mounjaro could lead to epidemic of ancient disease, warns ex-Olympian

A TEAM GB Olympian has warned that fat jabs could bring back an epidemic of scurvy. Former speed skater Sarah Lindsay believes injections such as Ozempic and Mounjaro — known as GLP-1 drugs — are leaving users malnourished and vitamin-deficient. Olivia West / News Group NewspapSarah Lindsay believes injections such as Ozempic and Mounjaro are leaving users malnourished and vitamin-deficient[/caption] AlamySarah warned of people getting sick ‘or …

Minnesota food companies factoring how weight-loss drugs affect snack sales

From General Mills to Hormel, the food industry is reckoning with more consumers on GLP-1 meds who are eating healthier and less.

Mounjaro is one of the needles used to treat type 2 diabetes. It has also magically contributed to weight loss for many people. Mounjaro has overcome gastric sleeve surgery and contributed to losing more than 30 kilograms for some people. Their lives have completely changed after they tried various diets and exercises to get rid of obesity...

Richard Groenendijk is a diabetic and is therefore given half a milligram of a well-known weight loss medication. While many celebrities lose weight with it, it has little effect on the 52-year-old comedian, he says in the podcast Lightless Lounge. "I weigh about 105 kilos."

How Ozempic and Similar Drugs Are Quietly Rewriting America’s Eating Habits

A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.

More people with type 1 diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety and effectiveness for the condition.